We require institutional CDAs as often the CDA will reference Florida Hospital and the investigator is not authorized to bind the institution to any legal agreement.  We encourage all of our investigators to submit CDAs to my office as the specific institutional terms can be entered and the confidential information can be legally shared amongst the investigator's staff or sub-investigators that might be interested in participating.  If you have any further questions please feel free to contact me.

Thank you,
Michelle Kilponen

Michelle Kilponen, MRA
Research Operations Specialist
Florida Hospital Office of Research Administration
901 N. Lake Destiny Rd. Suite 400
Maitland, FL 32751
Phone: 407-303-7756 ext 110-5879
Fax: 407-303-2567
Alternate Email Address: xxxxxx@flhosp.org

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of dougm (Doug Mounce)
Sent: Tuesday, April 21, 2015 10:46 AM
To: xxxxxx@lists.healthresearch.org
Subject: [Caution: Message contains Redirect URL content] [RESADM-L] personal vs. institutional CDAs

What reasons do folks have for preferring institutional to personal CDAs?  Institutional agreements allow sharing with co-workers, they give me an introduction to the contracting office, and I expect the institution's resources are being used during disclosure, but are there more formal, legal reasons recommending an institutional CDA?  I have accepted personal CDAs.  thanks!

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including  subscription information and a web-searchable archive, are available  via our web site at http://www.healthresearch.org (click on the  "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help ======================================================================

This message (including any attachments) is intended only for the use of the individual or entity to which it is addressed and may contain information that is non-public, proprietary, privileged, confidential, and exempt from disclosure under applicable law or may constitute as attorney work product. If you are not the intended recipient, you are hereby notified that any use, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, notify us immediately by telephone and (i) destroy this message if a facsimile or (ii) delete this message immediately if this is an electronic communication. Thank you.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.healthresearch.org (click on the
 "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help
======================================================================